TransDigm grants director Hennessy 589 stock options
The options vest in annual 20% increments over five years beginning September 30, 2027, subject to annual operating performance targets.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TransDigm Group director Sean P. Hennessy was granted 589 stock options on November 3, 2026, with an exercise price of $1,208.04 per share. The options are exercisable at 20% per year over five years beginning September 30, 2027, subject to achievement of annual operating performance targets in each year, and expire November 3, 2036. The reported post-transaction position was 589 options.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option F1 | 589 | $0.00 | $0.00 |
Footnotes (1)
- F1. These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to the achievement of annual operating performance targets in each year.
Key Figures
Key Terms
Stock Option financial
exercisable financial
annual operating performance targets financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many stock options did the TDG director receive?
What is the exercise price of Sean P. Hennessy's TDG options?
AI-generated analysis. How Rhea-AI works. Not financial advice.